Clinical Trial
doi: 10.1212/01.WNL.0000158680.89323.F8.
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP
Affiliations
- PMID: 15851750
- DOI: 10.1212/01.WNL.0000158680.89323.F8
Item in Clipboard
Clinical Trial
Clinical and electrophysiologic correlates of IVIg responsiveness in CIDP
Neurology.
.
Abstract
To identify clinical and electrophysiologic features related to IV immunoglobulin (IVIg) responsiveness in chronic inflammatory demyelinating polyneuropathy (CIDP), the authors conducted a multicenter study on 312 patients with CIDP (199 responders and 113 nonresponders). Muscle atrophy and decreased compound muscle action potential were pronounced in nonresponders of IVIg. Male gender, longer disease duration, and slow progression of symptoms were also associated with IVIg unresponsiveness. Features suggesting axonal dysfunction in peripheral nerves indicated IVIg unresponsiveness in CIDP.
Similar articles
-
Intravenous immunoglobulin as first treatment in diabetics with concomitant distal symmetric axonal polyneuropathy and CIDP.J Neurol. 2002 Jun;249(6):719-22. doi: 10.1007/s00415-002-0698-0. J Neurol. 2002. PMID: 12111305
-
Long-term effects of intravenous immunoglobulin in CIDP.Clin Neurophysiol. 2007 Sep;118(9):1980-4. doi: 10.1016/j.clinph.2007.05.001. Epub 2007 Jun 28. Clin Neurophysiol. 2007. PMID: 17604689
-
Nerve excitability changes after intravenous immunoglobulin infusions in multifocal motor neuropathy and chronic inflammatory demyelinating neuropathy.J Neurol Sci. 2010 May 15;292(1-2):63-71. doi: 10.1016/j.jns.2010.02.002. Epub 2010 Mar 10. J Neurol Sci. 2010. PMID: 20219211
-
Chronic inflammatory demyelinating polyneuropathy.Neuromuscul Disord. 2006 May;16(5):293-303. doi: 10.1016/j.nmd.2006.02.008. Neuromuscul Disord. 2006. PMID: 16631367 Review.
-
Chronic inflammatory demyelinating polyneuropathy in patients with systemic lupus erythematosus: prognosis and outcome.Semin Arthritis Rheum. 2005 Dec;35(3):175-84. doi: 10.1016/j.semarthrit.2005.08.008. Semin Arthritis Rheum. 2005. PMID: 16325658 Review.
Cited by
-
Treatment Responsiveness in CIDP Patients with Diabetes Is Associated with Higher Degrees of Demyelination.PLoS One. 2015 Oct 13;10(10):e0139674. doi: 10.1371/journal.pone.0139674. eCollection 2015. PLoS One. 2015. PMID: 26461125 Free PMC article.
-
Determinants of long-term disability in chronic inflammatory demyelinating polyradiculoneuropathy: A multicenter Korea/UK study of 144 patients.Eur J Neurol. 2025 Jan;32(1):e16575. doi: 10.1111/ene.16575. Eur J Neurol. 2025. PMID: 39654304 Free PMC article.
-
Treatment of chronic inflammatory demyelinating polyneuropathy.Curr Neurol Neurosci Rep. 2015 Jul;15(7):47. doi: 10.1007/s11910-015-0563-z. Curr Neurol Neurosci Rep. 2015. PMID: 26008811 Review.
-
Neurophysiological Hallmarks of Axonal Degeneration in CIDP Patients: A Pilot Analysis.Brain Sci. 2022 Nov 7;12(11):1510. doi: 10.3390/brainsci12111510. Brain Sci. 2022. PMID: 36358436 Free PMC article.
-
Autoantibodies Against Dihydrolipoamide S-Acetyltransferase in Immune-Mediated Neuropathies.Neurol Neuroimmunol Neuroinflamm. 2024 Mar;11(2):e200199. doi: 10.1212/NXI.0000000000200199. Epub 2024 Jan 5. Neurol Neuroimmunol Neuroinflamm. 2024. PMID: 38181320 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
